erythromycin has been researched along with diflomotecan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cendros, JM; Evans, TR; Falk, S; Graham, JS; Samuel, LM | 1 |
1 other study(ies) available for erythromycin and diflomotecan
Article | Year |
---|---|
A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Breath Tests; Camptothecin; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Erythromycin; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Staging; Neoplasms; Prognosis; Survival Rate; Tissue Distribution; Treatment Outcome; Young Adult | 2009 |